Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson's Disease.

Cellular and molecular neurobiology - 1 May 2020

Safari Fatemeh, Hatam Gholamreza, Behbahani Abbas Behzad, Rezaei Vahid, Barekati-Mowahed Mazyar, Petramfar Peyman, Khademi Farzaneh

Abstract excerpt

In recent years, the innovation of gene-editing tools such as the CRISPR/Cas9 system improves the translational gap of treatments mediated by gene therapy. The privileges of CRISPR/Cas9 such as working in living cells and organs candidate this technology for using in research and treatment of the central nervous system (CNS) disorders. Parkinson's disease (PD) is a common, debilitating, neurodegenerative disorder...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autism Spectrum Disorder Research
Share to Clustered Regularly Interspaced Short Palindromic Repeats

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CRISPR and Genetic Engineering

Share to Gene Editing

Share to Genetic Predisposition to Disease

Share to Parkinson Disease

Share to Phenotype

Share to Ubiquitin-Protein Ligases

Source

Identifiers

PMID: 31773362
DOI: 10.1007/s10571-019-00761-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson's Disease.PMID 31773362Read ↗

Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders.Semantic proximity Read ↗

Application of CRISPR/Cas9 in the management of Alzheimer’s disease and Parkinson’s disease: a reviewSemantic proximity Read ↗

A CRISPR-CAS9 high throughput machine-learning platform for modulation of genes involved in Parkinson’s disease-associated PINK1-mitophagy in iPSC-derived dopaminergic neuronsSemantic proximity Read ↗

CRISPR-Cas9 for treating hereditary diseases.Semantic proximity Read ↗

CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeuticsSemantic proximity Read ↗

Genome-editing applications of CRISPR-Cas9 to promote in vitro studies of Alzheimer's disease.Semantic proximity Read ↗

CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential.Semantic proximity Read ↗

Application of CRISPR genetic screens to investigate neurological diseasesSemantic proximity Read ↗

Modeling the genetic complexity of Parkinson's disease by targeted genome edition in iPS cells.Semantic proximity Read ↗

Finding the 'Guilty' Gene Variant of Sporadic Parkinson's Disease Via CRISPR/Cas9.Semantic proximity Read ↗

Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s diseaseSemantic proximity Read ↗

Advancement in CRISPR/Cas9 Technology to Better Understand and Treat Neurological Disorders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.